Northwestern Mutual Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13
Closed -$115 3458
2023
Q2
$115 Sell
13
-55
-81% -$586 ﹤0.01% 3264
2023
Q1
$713 Hold
68
﹤0.01% 3067
2022
Q4
$2.29K Sell
68
-11
-14% -$532 ﹤0.01% 2926
2022
Q3
$4K Sell
79
-140
-64% -$8.33K ﹤0.01% 2745
2022
Q2
$13K Hold
219
﹤0.01% 2417
2022
Q1
$17K Buy
219
+43
+24% +$6.36K ﹤0.01% 2368
2021
Q4
$36K Hold
176
﹤0.01% 2106
2021
Q3
$47K Buy
176
+108
+159% +$26K ﹤0.01% 1921
2021
Q2
$17K Hold
68
﹤0.01% 2255
2021
Q1
$20K Sell
68
-66
-49% -$20.5K ﹤0.01% 2056
2020
Q4
$34K Hold
134
﹤0.01% 1769
2020
Q3
$33K Hold
134
﹤0.01% 1635
2020
Q2
$47K Buy
134
+66
+97% +$20.6K ﹤0.01% 1462
2020
Q1
$18K Hold
68
﹤0.01% 1731
2019
Q4
$22K Hold
68
﹤0.01% 1715
2019
Q3
$18K Buy
+68
New +$24.9K ﹤0.01% 1759
2017
Q4
Sell
-13
Closed -$5K 2404
2017
Q3
$5K Buy
13
+1
+8% +$313 ﹤0.01% 1819
2017
Q2
$3K Buy
+12
New +$3.47K ﹤0.01% 1834
2015
Q1
Sell
-41
Closed -$10K 1725
2014
Q4
$10K Buy
+41
New +$8.76K ﹤0.01% 1075

Other funds holding NKTR

Northwestern Mutual Wealth Management's NKTR Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Nektar Therapeutics (NKTR) in Q3 2023, closing a stake of 13 shares — an estimated $115 sold.

Northwestern Mutual Wealth Management first reported a position in NKTR in Q4 2014 and held it in 19 quarters. The position peaked at $47K in Q3 2021. 138 funds tracked by Wall St. Rank hold NKTR as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Nektar Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 13 Nektar Therapeutics shares in Q3 2023, an estimated $115.
  • Northwestern Mutual Wealth Management first reported a position in Nektar Therapeutics in Q4 2014 and held it in 19 quarters.
  • Northwestern Mutual Wealth Management's Nektar Therapeutics position peaked at $47K in Q3 2021.
  • 138 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.